Get started Log in

4974 — Takara Bio Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Market Cap
¥138bn
Enterprise Value
¥128bn
Revenue
¥40bn

Japanese stocks rise on U.S. stimulus optimism
21/10/2020 07:44
Japan shares recover on U.S. stimulus hopes
21/10/2020 03:53
Table: Takara Bio Inc. -2020 6-month group forecast
20/10/2020 07:00
Factbox: The race for a coronavirus vaccine
28/09/2020 21:29
Table: Takara Bio -Q1 group results
04/08/2020 07:00
Brief: Takara Bio USA And BioSyntagma Develop Method For Large-Scale Automated COVID-19 Testing
08/06/2020 13:16
Brief: Takara Bio Selects AGC Biologics As Manufacturer Of Plasmid DNA Intermediate For A Vaccine Against COVID-19
21/05/2020 07:08
Media: Takara's saliva-based coronavirus test to allow samples taken at home - Nikkei
16/05/2020 17:42
Table: Takara Bio -2019/20 group results
14/05/2020 07:00
Brief: Tasly Pharmaceutical's Unit Signs C-REV License Agreement With Japan's Takara Bio
11/05/2020 11:43
Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals (updated)
24/03/2020 01:36
Table: Takara Bio - 9-MTH group results
13/02/2020 06:00
Table: Takara Bio - 6-MTH group results
12/11/2019 06:00
Table: Takara Bio -Q1 group results
06/08/2019 07:00
Table: Takara Bio -2018/19 group results
14/05/2019 07:00
Table: Takara Bio - 9-MTH group results
30/01/2019 06:00
Table: Takara Bio - 6-MTH group results
06/11/2018 06:00
Brief: Takara Bio to transfer health foods business to SHIONOGI HEALTHCARE for 534.8 mln yen
20/09/2018 08:14
Table: Takara Bio -Q1 group results
31/07/2018 07:00
Table: Takara Bio -2017/18 group results
11/05/2018 07:01